Biotech News

Creative Medical Technology Holdings Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome™ Knee Osteoarthritis Study

Creative Medical Technology Holdings (CELZ)Creative Medical Technology HoldingsConference / presentation

International Scientific Presentation Underscores Encouraging Clinical Outcomes and Additional Biological Potency Findings Supporting Cell-Free Regenerative Platform International Scientific Presentation Underscores Encouraging Clinical Outcomes and Additional Biological Potency Findings Supporting Cell-Free Regenerative Platform

Related news

Creative Medical Technology Holdings

Creative Medical Technology Holdings is a regenerative medicine company focused on cell-based and biologic approaches to difficult diseases. Its story is built around early-stage platform science and the possibility of translating regenerative concepts into practical therapies.

Recent company news

Stock data

Close
0.44 USD
Market cap
8.24M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States